Frontiers in Pharmacology
Scope & Guideline
Driving excellence in pharmacological research and education.
Introduction
Aims and Scopes
- Pharmacological Mechanisms and Drug Action:
The journal emphasizes research that elucidates the mechanisms of drug action at molecular, cellular, and systemic levels, contributing to the understanding of how drugs interact with biological systems. - Clinical Pharmacology and Therapeutics:
Publications often focus on the clinical application of pharmacological principles, including studies on drug efficacy, safety, and the pharmacokinetics and pharmacodynamics of various therapeutic agents. - Natural Products and Traditional Medicine:
There is a strong interest in exploring natural compounds and traditional herbal medicines, investigating their pharmacological effects, mechanisms of action, and potential therapeutic applications. - Pharmacogenomics and Personalized Medicine:
Research on genetic variations affecting drug metabolism and response is a significant area, promoting the development of personalized medicine approaches to optimize drug therapies. - Drug Safety and Pharmacovigilance:
The journal covers studies related to drug safety, adverse effects, and pharmacovigilance, highlighting the importance of monitoring and evaluating drug-related outcomes in clinical settings. - Innovative Drug Delivery Systems:
Research on novel drug delivery technologies, including nanoparticles and other advanced formulations, is also featured, aiming to enhance drug efficacy and reduce side effects.
Trending and Emerging
- Integrated Omics Approaches:
There is a significant rise in studies employing integrated omics methodologies (genomics, proteomics, metabolomics) to understand drug mechanisms and disease pathology, reflecting a trend towards holistic research perspectives. - Targeting the Gut Microbiome:
Research focusing on the gut microbiome's role in drug metabolism, efficacy, and disease treatment is gaining traction, highlighting its importance in personalized medicine and therapeutic outcomes. - Emerging Therapeutics and Drug Repurposing:
The journal is increasingly publishing articles on the repurposing of existing drugs for new therapeutic uses, emphasizing the potential of known compounds in treating various diseases. - Nanotechnology in Drug Delivery:
The application of nanotechnology for drug delivery systems is a rapidly growing area, with numerous studies investigating how nanoparticles can enhance the efficacy and safety of therapeutic agents. - Pharmacogenomics and Precision Medicine:
The focus on pharmacogenomics is expanding, with more research dedicated to understanding genetic influences on drug response, which is crucial for developing precision medicine strategies. - Natural Products as Therapeutic Agents:
A resurgence in interest for natural products, including herbal medicines and their bioactive components, is evident, particularly in their roles as potential candidates for innovative therapies.
Declining or Waning
- Conventional Pharmacological Approaches:
There has been a noticeable shift from traditional pharmacological studies towards more integrative and innovative methodologies, including systems biology and multi-omics approaches, reflecting a decline in purely conventional pharmacology research. - Single-Agent Drug Studies:
Research focusing solely on the effects of single-agent drugs is becoming less common, as there is a growing preference for studies that explore combination therapies and polypharmacology to address complex diseases. - Basic Pharmacology without Clinical Relevance:
Papers that do not bridge basic pharmacology with clinical applications are less frequently accepted, indicating a trend towards research that has direct implications for therapeutic practices. - Static Drug Interaction Studies:
The field is moving away from static studies of drug interactions to more dynamic models that incorporate patient-specific factors, highlighting a decline in traditional drug interaction research.
Similar Journals
DRUG DEVELOPMENT RESEARCH
Advancing pharmaceutical innovation through rigorous research.DRUG DEVELOPMENT RESEARCH is a premier interdisciplinary journal published by Wiley, focusing on the latest advancements in drug discovery, pharmacology, and toxicology. With an ISSN of 0272-4391 and an E-ISSN of 1098-2299, this esteemed publication has been a cornerstone in the field since its inception in 1981 and continues to provide cutting-edge research until 2024. Its rigorous peer-review process and strategic placement in Q2 of the Drug Discovery category, as well as ranking #60 out of 157 in Scopus, underscore the journal's relevance and influence, boasting a respectable 62nd percentile ranking. While the journal does not currently offer open access, it remains a vital resource for researchers, professionals, and students seeking to expand their knowledge on the processes of drug development, identifying new therapeutic targets, and assessing the efficacy and safety of novel compounds. Situated in Hoboken, NJ, this journal stands at the forefront of pharmaceutical innovation, making significant contributions to the advancement of medical science.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Transforming Knowledge into Therapeutic SolutionsThe JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.
European Journal of Pharmacology
Unveiling groundbreaking research in pharmacokinetics and toxicology.The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.
International Journal of Pharmacology
Bridging Research and Application in PharmacologyWelcome to the International Journal of Pharmacology, a key publication in the field of pharmacology, published by ASIAN NETWORK SCIENTIFIC INFORMATION (ANSINET). Since its inception in 2006, this journal has provided a vital platform for researchers and professionals to disseminate their findings and insights in pharmacology, toxicology, and pharmaceutics. Despite recent discontinuation in Scopus coverage, the journal's dedication to fostering scientific dialogue continues to attract contributions from esteemed scholars globally. With an **ISSN of 1811-7775** and **E-ISSN of 1812-5700**, the journal seeks to bridge the gap between laboratory research and clinical application, promoting a deeper understanding of drug actions and interactions. Although it operates under traditional access options, the relevance of its published studies to ongoing pharmacological research remains significant.
Research in Pharmaceutical Sciences
Fostering Excellence in Pharmaceutical ResearchResearch in Pharmaceutical Sciences is a premier, peer-reviewed journal published by Wolters Kluwer Medknow Publications, dedicated to advancing the field of pharmacology, toxicology, and pharmaceutics. With an impact factor that positions it in the second quartile of its category (Q2) and a respectable rank of 23 out of 80 in Scopus, this journal serves as an essential platform for researchers, professionals, and students alike, providing open access since 2015 to a wealth of pioneering studies and comprehensive reviews. Based in Mumbai, India, the journal encompasses a diverse range of topics within the pharmaceutical sciences, offering insights that address both theoretical and practical challenges in drug development and safety. As it converges from 2009 to 2024, Research in Pharmaceutical Sciences continues to be a vital source of knowledge, promoting innovation and fostering collaboration within the global scientific community.
BRITISH JOURNAL OF PHARMACOLOGY
Elevating research standards in the field of pharmacology.British Journal of Pharmacology is a premier, peer-reviewed journal published by Wiley, specializing in the dynamic field of pharmacology. With a robust impact factor, this journal ranks in the top quartile (Q1) for pharmacology according to the 2023 category rankings, emphasizing its significance and reputation among the global scientific community. As an essential resource for researchers, professionals, and students alike, the journal provides a platform for innovative research spanning foundational studies to clinical applications in pharmacology, toxicology, and pharmaceutics. Since its inception in 1966, the journal has consistently contributed to the advancement of pharmacological science, fostering a deeper understanding of drug action mechanisms and therapeutic advancements. Although primarily subscription-based, the British Journal of Pharmacology is committed to disseminating high-quality research that shapes the future of the field.
JOURNAL OF CLINICAL PHARMACOLOGY
Empowering Healthcare with Evidence-Based PharmacologyWelcome to the Journal of Clinical Pharmacology, an esteemed publication in the field of pharmacology and medical pharmacology, published by Wiley. Since its inception in 1973, this journal has been at the forefront of disseminating innovative research findings and comprehensive reviews that enhance our understanding of drug therapies and their clinical applications. With an impact factor that reflects its strong reputation and a Scopus ranking placing it in the 64th percentile among 272 journals in medical pharmacology, the journal stands as a critical resource for researchers, healthcare professionals, and students alike. Although currently not an Open Access journal, it provides invaluable insights into therapeutic drug use and safety, the pharmacokinetics of drugs, and the development of new therapeutic strategies. The journal's commitment to advancing the field through high-quality, peer-reviewed articles ensures it remains a vital asset in the continuously evolving landscape of clinical pharmacology.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
Exploring innovative therapies through rigorous research.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, published by DUSTRI-VERLAG DR KARL FEISTLE in Germany, is a vital scholarly platform dedicated to advancing the field of pharmacology through rigorous research and innovative therapeutic strategies. Established in 1994, this journal has maintained its relevance in the evolving landscape of clinical pharmacology, achieving a Q3 rank in both general and medical pharmacology categories as of 2023. With an ISSN of 0946-1965, it is positioned as an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of drug therapy and pharmacological applications. Though it currently does not offer open access, its comprehensive scope covers a wide array of topics within pharmacology, promising to contribute significantly to scientific discussions and knowledge dissemination from 1994 to 2024. Whether you are looking for the latest studies or historical insights, the journal remains a fixture for anyone invested in the pharmacological sciences.
INDIAN JOURNAL OF PHARMACOLOGY
Fostering excellence in pharmacology through rigorous inquiry.INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.
FUNDAMENTAL & CLINICAL PHARMACOLOGY
Fostering excellence in pharmacological sciences and clinical practice.FUNDAMENTAL & CLINICAL PHARMACOLOGY is a distinguished journal dedicated to advancing the fields of pharmacology and clinical medicine. Published by WILEY, this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike to disseminate innovative research findings and clinical applications. With an impressive history spanning from 1987 to 2024, it has consistently maintained its relevance in the scientific community, evidenced by its Q2 quartile ranking in both Pharmacology and Pharmacology (medical) categories for 2023. The journal's diverse publication range, which includes original research articles, reviews, and clinical studies, helps bridge the gap between fundamental research and practical application in healthcare settings. Although it does not offer open access, its rigorous peer-review process ensures that published content meets the highest scholarly standards, making it a vital resource for those aiming to stay at the forefront of pharmacological sciences.